N-Iodosuccinimide → (5-Iodo-imidazo[2,1-b][1,3,4]thiadiazol-2-yl)-propyl-amine

HRID 1942316Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1942316
[S:1]1[C:5]([NH:6][CH2:7][CH2:8][CH3:9])=[N:4][N:3]2[CH:10]=[CH:11][N:12]=[C:2]12.[I:13]N1C(=O)CCC1=O>C(#N)C>[I:13][C:10]1[N:3]2[C:2]([S:1][C:5]([NH:6][CH2:7][CH2:8][CH3:9])=[N:4]2)=[N:12][CH:11]=1

Komponenten

4

Edukt 2

HCID 120273N-IodosuccinimideHCID 58285612Imidazo[2,1-b][1,3,4]thiadiazol-2-yl-propyl-amine

Produkt 1

HCID 58285729(5-Iodo-imidazo[2,1-b][1,3,4]thiadiazol-2-yl)-propyl-amineAusbeute 36,6 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6342AcetonitrileLösungsmittel

Versuchsvorschrift

663 mg of imidazo[2,1-b][1,3,4]thiadiazol-2-yl-propyl-amine were dissolved in 20 ml of acetonitrile. 822 mg of N-iodosuccinimide were added to the solution. The reaction mixture was stirred for 4 h at room temperature. For work-up, the mixture was cooled on ice and filtrated. 410 mg of the desired product were obtained.

Aufarbeitung

  1. temperatureFor work-up, the mixture was cooled on ice
  2. filtrationfiltrated

Quellen und Nachweise

ORD-Eintrag
ord-4683d2492c044513aec3142526f604e8
Quelldatensatz
uspto-grants-2013_03
Patentnummer
US08389554B2

Notizen zur Reaktion

Wird geladen…